Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2023 Earnings Call Transcript November 6, 2023
Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.08.
Matt Scalo: Good afternoon and welcome to Myriad Genetics Third Quarter 2023 Earnings Call. During the call, we will review the financial results we released today. And afterwards, we will host a question-and-answer session. Our quarterly earnings release was issued this afternoon on Form 8-K and can be...
